2-(4-Chloro-2-cyano-2-phenylbutyl)aziridines were employed for the one-step stereoselective construction of both endo- and exo-2-aminomethyl-4-phenyl-1-azabicyclo[2.2.1]heptanes as new azaheterobicyclic scaffolds via a double LiAlH(4)-induced reductive cyclization protocol. Antiplasmodial assessment of these 1-azabicyclo[2.2.1]heptanes revealed moderate to good activities in the micromolar range, with the exo-isomers being the most promising structures. Furthermore, the proposed mode of action was supported by ligand docking studies, pointing to a strong binding interaction with the enzyme plasmepsin II.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2012.12.029DOI Listing

Publication Analysis

Top Keywords

reductive cyclization
8
synthesis 2-aminomethyl-4-phenyl-1-azabicyclo[221]heptanes
4
2-aminomethyl-4-phenyl-1-azabicyclo[221]heptanes lialh₄-induced
4
lialh₄-induced reductive
4
cyclization 2-4-chloro-2-cyano-2-phenylbutylaziridines
4
2-4-chloro-2-cyano-2-phenylbutylaziridines evaluation
4
evaluation antimalarial
4
antimalarial activity
4
activity 2-4-chloro-2-cyano-2-phenylbutylaziridines
4
2-4-chloro-2-cyano-2-phenylbutylaziridines employed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!